Archive | Diagnostics and Tools Portfolio

Rayno Life Science Performance: Up 21%+ YTD…FBT, GILD, ILMN

Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of the market  YTD with our top ETF pick (FBT) up 31% YTD and 3.66% over five days.The IBB is […]

Continue Reading 0

Trading A Bottom in Small Cap Life Science Stocks …Update 10/28 PM

10/28 Rallies Rule Small caps on fire with IWM up 2.58% to 113.58. NASDAQ in fourth day of rally from 10/23 bottom. Small cap speculative picks are all up from 10/16 : Today CLDX up 9.34%, PACB up 0.8%, XBI up 2.4%. And the biotech rally is very broad: Rayno Large Cap Biopharma: up 33.6% […]

Continue Reading

BABA Hangover: Stock Sell-Off Continues… Update-1… 10/3 Robust Job Growth

10/3  Jobs Report Clears Path for Q4 Rally   3:30P EDT A more optimistic view of the economy was triggered by a steady gain in jobs with 248k added in August and unemployment dropping below 6% to 5.9%. But average hourly wages fell in September keeping wage growth rate around inflation at 2%. Little inflation […]

Continue Reading

Rayno Life Science: Trading Notes End of August

As we move into a heavier trading period watch your portfolio for changes as volume picks up. Here are some of our long term portfolio winners where you can take profits: Exact Sciences (EXAS) short squeeze took it to $22. Illumina (ILMN) triple to at $180. Here are a few laggard stocks with bullish momentum: […]

Continue Reading

Rayno DX and Tools Mid Year Review and AACC Update: ABAX, ILMN, HOLX, TMO.. Update-2

Update -2 Aug. 1 Draft Guidance on LDTs Coming from FDA in 60 Days: Tests Must Be Validated More regulation coming means greater development costs and potential time delays for clinical tests in development and currently marketed as LDTs . Presumably LDT tests will be allowed to remain on the market. Potential intermediate term impact […]

Continue Reading